Page 32 - சுயாதீனமான தகவல்கள் கண்காணிப்பு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lynparza crosses superiority boundary for invasive disease-free survival

Lynparza crosses superiority boundary for invasive disease-free survival
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Data monitoring committeeIndependent data monitoring committeeதகவல்கள் கண்காணிப்பு குழுசுயாதீனமான தகவல்கள் கண்காணிப்பு குழு

AstraZeneca (LSE:AZN) | RNS | AstraZeneca PLC - Lynparza: IDMC recommend early analysis of OlympiA

AstraZeneca (LSE:AZN) | RNS | AstraZeneca PLC - Lynparza: IDMC recommend early analysis of OlympiA
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomBruxelles capitaleCity ofDaiichi sankyoAndrew tuttRoy baynesAdrian kempClin genetNational surgical adjuvant breastCompany on twitterFrontier science technology research foundationMerck co incBreast international groupGynaecologic oncology groupHead of global clinical developmentDevelopment agreement

Chinese CanSinoBio becomes fourth Covid-19 vaccine to be approved in Pakistan

The government has approved China’s CanSinoBio Covid-19 vaccine for emergency use in Pakistan, Special Assistant to the Prime Minister on Health Dr. Faisal Sultan said on Friday. Drug Regulatory Authority of Pakistan (DRAP) has already approved three other vaccines for use in Pakistan - China s Sinopharm, Russia s Sputnik-V and the Oxford University-AstraZeneca vaccine. Drap officials said that after its approval for emergency use, the supply of the doses will start in a few weeks. Cansino Bio is the only vaccine for which Pakistan conducted a clinical trial, with around 18,000 volunteers participating from across the country. The analysis, which was released by the Independent Data Monitoring Committee (IDMC), showed that it had 74.48 per cent efficacy rate in preventing symptomatic cases and 100 per cent in preventing severe disease.

Cansino bioFaisal sultanCansinobio covidDrug regulatory authority of pakistanHealth drData monitoring committeeOxford universityMinistry of national health servicesSpecial assistantPrime ministerRegulatory authorityOxford university astrazenecaIndependent data monitoring committeeNational healthChinese cansinobioFourth covid19 vaccine

Another Chinese vaccine gets nod for emergency use in Pakistan

Another Chinese vaccine gets nod for emergency use in Pakistan The Drug Regulatory Authority of Pakistan has issued emergency use authorization to the COVID-19 vaccine by Chinese company Cansino Biologics Inc. | 14 Feb 2021 8:18 AM GMT ISLAMABAD: The Drug Regulatory Authority of Pakistan (Drap) has issued emergency use authorization to the COVID-19 vaccine by Chinese company Cansino Biologics Inc, officials said, adding the supply of the doses will begin in a few weeks. It will become the fourth vaccine to be allowed for emergency use in Pakistan, the Dawn news reported. Cansino Biologics Inc is the only company that has conducted clinical trials in Pakistan, with around 18,000 volunteers participating from across the country.

Cansino bioGame developer company giftedCansino biologics incDrap clinical trial committeeDrug regulatory authority of pakistan drapAga khan universityData monitoring committeeUniversity of health sciencesDrug regulatory authorityBiologics incIndependent data monitoring committeeClinical trial committeeHealth sciencesAssam govtDrug regulatory authority of pakistanகேன்சினோ உயிர்

Pakistan approves fourth Covid-19 vaccine

Pakistan approves fourth Covid-19 vaccine Top Searches Pakistan approves fourth Covid-19 vaccine PTI / Feb 13, 2021, 12:19 IST FacebookTwitterLinkedinEMail A health worker receives a dose of Sinopharm s coronavirus disease vaccine at a vaccination centre in Karachi ISLAMABAD: Pakistan has approved the emergency use of a second Chinese Covid-19 vaccine, making it the fourth drug to be cleared by the regulatory authority to tackle the deadly virus, which has claimed over 12,000 lives in the country. Chinese company Cansino Biologics Inc s vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday. Drap officials said that after its approval for emergency use, the supply of the doses will start in a few weeks.

United kingdomCansino bioSajid shahJaved akramCansino biologics incNational health servicesDrug regulatory authority of pakistan drap onData monitoring committeeAga khan universityUniversity of health sciencesMinistry of national health servicesDrug regulatory authorityIndependent data monitoring committeeHealth sciencesBaga khanChancellor dr javed akram